Acute Kidney Injury Ajay Dhaygude Admitting specialty Inadequate - - PowerPoint PPT Presentation

acute kidney injury
SMART_READER_LITE
LIVE PREVIEW

Acute Kidney Injury Ajay Dhaygude Admitting specialty Inadequate - - PowerPoint PPT Presentation

Acute Kidney Injury Ajay Dhaygude Admitting specialty Inadequate risk assessment Missed complications AKI vs ACS Cardiac muscle Vs Pre, intra and post AKI Rapidity & symptoms Biomarker[s] Relationship between GFR and Serum


slide-1
SLIDE 1

Acute Kidney Injury

Ajay Dhaygude

slide-2
SLIDE 2
slide-3
SLIDE 3

Admitting specialty

slide-4
SLIDE 4

Inadequate risk assessment

slide-5
SLIDE 5

Missed complications

slide-6
SLIDE 6
slide-7
SLIDE 7

AKI vs ACS

  • Cardiac muscle

Vs Pre, intra and post AKI

  • Rapidity & symptoms
  • Biomarker[s]
slide-8
SLIDE 8
slide-9
SLIDE 9

Relationship between GFR and Serum creatinine

slide-10
SLIDE 10
slide-11
SLIDE 11

Epidemiology

  • UK data 172 to 630 pmp/yr
  • AKI requiring dialysis: 200 pmp/year
  • ICU national audit: 4.9% patients have AKI and 10% bed

days are accounted for AKI

  • Mortality: uncomplicated- 10%

with MOF: 50% With RRT: 80%

  • Financial implications- £ 450-600 million/yr

(more than Skin, breast and lung cancer treatment together)

slide-12
SLIDE 12

Definition and stages

  • Serum creatinine rises by ≥ 26.5 μmol/L within 48 hours or
  • Serum creatinine rises ≥ 1.5 fold from the reference value,

which is known or presumed to have occurred within one week or

  • urine output is < 0.5ml/kg/hr for >6 consecutive hours
  • Stage 1: 1.5 to 1.9 times raised S Cr.
  • Stage 2: 2 to 2.9 times raised S Cr.
  • Stage 3: S Cr more than 3 times high or absolute increase

by 353 mmol/lr OR need to start dialysis

slide-13
SLIDE 13

Selby et al PLoS One. 2012; 7(11): e48580.

slide-14
SLIDE 14

Risk factors

slide-15
SLIDE 15

Case-1

  • JW-83 Yrs old, back ground, CKD, IHD
  • Admitted with Cl diff diarrhoea.
  • Inspite of oral vancomycin + rehydration

developed AKI

  • Ref by ITU cons at CDH:
  • Decreased UOP (?). BP 110 systolic, apyrexial
  • Urea- 24.9, K- 4.6, Creat 423, (CRP improving)
  • pH 7.2, base excess -11, bicarb 15
  • Pt has received 6 litres fluid in last 48 hours now

RR 18, basal crackles, gases okay

slide-16
SLIDE 16

Results

slide-17
SLIDE 17
slide-18
SLIDE 18
  • How do you treat him?
  • ?diuretics
  • Urgent dialysis
  • Anything else
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22

Diuretics in AKI, Bagshaw et al

  • 67% clinicians use diuretics in AKI
  • 86% patients had pulmonary oedema
  • IV Furosemide was most commonly used drug
  • Most clinicians were aware of toxicity, effect on

renal recovery.

  • Most were willing to take part in RCT
slide-23
SLIDE 23

Diuretics in AKI

  • Use if:

– Fluid overloaded – Not hypotensive (?)

  • Use single large dose [up to 250 mg iv over 4

hours]

  • If no response then abandon further use
  • Monitor electrolytes/ fluid balance
  • Can enhance gentamicin toxicity
  • Diuretics does not cure AKI !!!
slide-24
SLIDE 24

Case-2

  • LH- 53 years young previously fit and well female

patient is admitted with sudden onset severe abdominal pain.

  • On admission found to be confused, hypotensive
  • Rapid deterioration requiring ventilation and

inotropic suport.

slide-25
SLIDE 25

How will you investigate her?

  • CT abd excluded ischaemic bowel.
slide-26
SLIDE 26

Biochemistry

slide-27
SLIDE 27
slide-28
SLIDE 28

Transferring patients with AKI

  • Death during transfer should be avoided at

any cost

  • Get your critical care team involved if your

patients has-

– Severe acidosis, – refractory hyperkalemia, – haemodynamically unstable patients and severe pulmonary oedema

slide-29
SLIDE 29

Cause of death in AKI, Selby et al

slide-30
SLIDE 30

Early Goal-Directed Therapy in the Treatment

  • f Severe Sepsis and Septic Shock

Emanuel Rivers, M.D., M.P.H., Bryant Nguyen, M.D., Suzanne Havstad, M.A., Julie Ressler, B.S., Alexandria Muzzin, B.S., Bernhard Knoblich, M.D., Edward Peterson, Ph.D., Michael Tomlanovich, M.D., for the Early Goal-Directed Therapy Collaborative Group

Volume 345: 1368-1377 November 8, 2001

Sepsis and the critically ill

slide-31
SLIDE 31

Protocol group

slide-32
SLIDE 32
slide-33
SLIDE 33

Treatment given

0-6 hours 7-72 hours 0-72 hours Fluids (ml) EGDT 4991 8625 13443 Standard 3499 10602 13358 P value <0.001 0.01 0.73 RBC transfusion (%) EGDT 64.1 11.1 68.4 Standard 18.5 32.8 44.5 P value <0.001 <0.001 <0.001 Vasopressor use (%) EGDT 27.4 29.1 36.8 Standard 30.3 42.9 51.3 P value 0.62 0.03 0.02 Dobutamine use (%) EGDT 13.7 14.5 15.4 Standard 0.8 8.4 9.2 P value <0.001 0.14 0.15 Mechanical ventilation (%) EGDT 53.0 2.6 55.6 Standard 53.8 16.8 70.6 P value 0.90 <0.01 0.02

slide-34
SLIDE 34

Electrolyte contents of some common fluids

slide-35
SLIDE 35

Case-3

  • IW- 70 Year old pt with H/O NHL is admitted with

generalised oedema, and feeling unwell.

  • Finished chemotherapy 5 months ago, in remission.
  • O/E Gross oedema, hypotensive and tachypnoeic
  • CXR- Pulmonary oedema.
  • What investigations are needed?
slide-36
SLIDE 36
slide-37
SLIDE 37

Biochemistry

slide-38
SLIDE 38

She is known to have severe biventricular failure due to valvular heart disease.

slide-39
SLIDE 39

Management of cardio-renal syndrome

  • Diuretics Optimisation Strategies Evaluation trial:

308 pts low or high dose furosemide given as 12 hourly boli or continuous infusion.

  • No difference in infusion or bolus regime
  • High dose was associated with better response but

higher likelyhood of renal impairment [23% vs 14%]

  • CARRESS-HF trial: compared haemofiltration

versus stepped pharmacologic therapy. Later approach was superior.

slide-40
SLIDE 40

Case-4

  • AD, 79 yrs old male presented with haematuria and

during hospital stay developed AKI

slide-41
SLIDE 41

How would you investigate?

slide-42
SLIDE 42
slide-43
SLIDE 43

Missed investigations -NCEPOD

slide-44
SLIDE 44

Case-5

  • GB, 65 yr old pt with known CKD III was admitted with PR
  • bleed. Sigmoidoscopy was normal but was found to have

weight loss and was hospitalised.

  • Developed progressive AKI in hospital. Referred to medics
  • Also has purpuric rash, haematuria and haemoptysis.
  • CT chest- widespread nodular shadow, bronchoscopy-

pulmonary haemorrhage.

  • Became anuric and was transferred to HDU for

haemofiltration

slide-45
SLIDE 45
slide-46
SLIDE 46

How do you investigate further?

  • How do you manage this patient?
  • Urgent renal referral please.
slide-47
SLIDE 47

Hyperkalaemia

slide-48
SLIDE 48

Hyperkalaemia

  • Do an ECG + attach to cardiac monitor
  • 10ml 10% Calcium Gluconate; repeat until ECG normalizes
  • Nebulised Salbutamol (5-10mg)
  • 50ml 50% Dextrose + 10 unit Insulin
  • iv Sodium Bicarbonate (50-100ml 8.4% NaHCO3 via central line)
  • Calcium Resonium (30g rectally)
slide-49
SLIDE 49

Fluid overload Pulmonary Oedema

  • Furosemide 500mg iv over 1 hour
  • Oxygen
  • Opiates
  • Nitrate iv

Dialysis if refractory to above

Pericarditis

  • Pericarditis
  • More common in chronic renal failure than ARF
  • Risk of progression to tamponade
slide-50
SLIDE 50

Acidosis Severe Acidosis

  • eg if pH <7.1

Symptomatic uraemia Symptomatic Uraemia

  • Confusion, coma, asterixis
slide-51
SLIDE 51

Do I put in a central line? Do I test the urine? Do I use diuretic? Do I use Dopamine? Do I give any other drugs? Do I ask for urgent dialysis? Only if uncertain of volume status Of course Only for fluid overload No No If hyperkalaemia, fluid overload, pericarditis, acidosis

Do’s and Don’ts

slide-52
SLIDE 52

The take-home message

  • AKI is associated with significant mortality and has

financial implications.

  • Elderly patients are at increased risk
  • Small rise in Creatinine suggests big drop n GFR
  • Sepsis is commonest cause of death
  • Remember acidosis!
slide-53
SLIDE 53

Indications for Dialysis

Persistent hyperkalaemia Fluid overload Pericarditis Acidosis Symptomatic uraemia

slide-54
SLIDE 54
slide-55
SLIDE 55

AKI= FLUIDS

  • F fluid balance
  • L low BP
  • U urine dipstics
  • I imaging
  • D drugs
  • S sepsis
slide-56
SLIDE 56

Case -6

65Yr M. Admitted to BVH ITU with Creat 1100 H/o travel to Tenerife and developed some D&V PMH- Known single kidney (Creat 180- 3 months ago) USS ?Obstruction- nephrostomy- no Urine CT Pelvis- no cause for obstruction found Transferred to RPH- Immunology negative Kidney biopsy: crescentic GN+ Ischaemic changes + CPN Renal angio- RAS- Stented, antibiotics Remained on dialysis. Died after 6 months (line sepsis)